Levels of perfluoroalkyl substances and risk of coronary heart disease: Findings from a population-based longitudinal study.

[1]  Brian A. King,et al.  Validation of self-reported smokeless tobacco use by measurement of serum cotinine concentration among US adults. , 2014, American journal of epidemiology.

[2]  K. Steenland,et al.  Modeled PFOA Exposure and Coronary Artery Disease, Hypertension, and High Cholesterol in Community and Worker Cohorts , 2014, Environmental health perspectives.

[3]  Yonglong Lu,et al.  Associations between serum concentrations of perfluoroalkyl acids and serum lipid levels in a Chinese population. , 2014, Ecotoxicology and environmental safety.

[4]  A. Shankar,et al.  The association between PFOA, PFOS and serum lipid levels in adolescents. , 2014, Chemosphere.

[5]  K. Chien,et al.  Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults. , 2013, International journal of cardiology.

[6]  A. Tjønneland,et al.  Association between Plasma PFOA and PFOS Levels and Total Cholesterol in a Middle-Aged Danish Population , 2013, PloS one.

[7]  T. Arbuckle,et al.  Do perfluoroalkyl substances affect metabolic function and plasma lipids?--Analysis of the 2007-2009, Canadian Health Measures Survey (CHMS) Cycle 1. , 2013, Environmental research.

[8]  K. Steenland,et al.  Cohort mortality study of workers exposed to perfluorooctanoic acid. , 2012, American journal of epidemiology.

[9]  A. Shankar,et al.  Perfluorooctanoic acid and cardiovascular disease in US adults. , 2012, Archives of internal medicine.

[10]  Roel Vermeulen,et al.  Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations. , 2012, Chemosphere.

[11]  Anders Bignert,et al.  Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996-2010. , 2012, Environmental science & technology.

[12]  J. Min,et al.  Perfluorooctanoic acid exposure is associated with elevated homocysteine and hypertension in US adults , 2012, Occupational and Environmental Medicine.

[13]  P. Ayotte,et al.  Effects of perfluorooctanesulfonate exposure on plasma lipid levels in the Inuit population of Nunavik (Northern Quebec). , 2010, Environmental research.

[14]  D. Savitz,et al.  Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA) , 2010, Environmental health perspectives.

[15]  Kyle Steenland,et al.  Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. , 2009, American journal of epidemiology.

[16]  T. Webster,et al.  Exposure to Polyfluoroalkyl Chemicals and Cholesterol, Body Weight, and Insulin Resistance in the General U.S. Population , 2009, Environmental health perspectives.

[17]  B. Alexander,et al.  Ammonium Perfluorooctanoate Production and Occupational Mortality , 2009, Epidemiology.

[18]  Tony Fletcher,et al.  The C8 Health Project: Design, Methods, and Participants , 2009, Environmental health perspectives.

[19]  J. M. Symons,et al.  Ischaemic heart disease mortality study among workers with occupational exposure to ammonium perfluorooctanoate , 2009, Occupational and Environmental Medicine.

[20]  Hermann Fromme,et al.  Perfluorinated compounds--exposure assessment for the general population in Western countries. , 2009, International journal of hygiene and environmental health.

[21]  Cathrine Thomsen,et al.  Time trends and the influence of age and gender on serum concentrations of perfluorinated compounds in archived human samples. , 2009, Environmental science & technology.

[22]  Jiantong Wang,et al.  Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. , 2009, American journal of epidemiology.

[23]  Aruni Bhatnagar,et al.  Environmental Risk Factors for Heart Disease , 2008, Reviews on Environmental Health.

[24]  J. Kotlerman,et al.  Self-Reported Health Effects among Community Residents Exposed to Perfluorooctanoate , 2008, New solutions : a journal of environmental and occupational health policy : NS.

[25]  C. Lau,et al.  Perfluoroalkyl acids: a review of monitoring and toxicological findings. , 2007, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  Aruni Bhatnagar,et al.  Environmental cardiology: studying mechanistic links between pollution and heart disease. , 2006, Circulation research.

[27]  E. Stiernström,et al.  Musculoskeletal Symptoms among Farmers and Non-farmers: A Population-based Study , 2002, International journal of occupational and environmental health.

[28]  Walter C Willett,et al.  Balancing Life-Style and Genomics Research for Disease Prevention , 2002, Science.

[29]  J. Manson,et al.  Primary prevention of coronary heart disease in women through diet and lifestyle. , 2000, The New England journal of medicine.

[30]  J. Slattery,et al.  Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.

[31]  David B Richardson,et al.  Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study. , 2014, Environment international.

[32]  A. Alwan.  Global status report on noncommunicable diseases 2010. , 2011 .

[33]  J. M. Symons,et al.  Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers. , 2008, Annals of epidemiology.

[34]  K. Svärdsudd,et al.  Geographical variation of mortality from cardiovascular diseases. The Project 'Myocardial Infarction in mid-Sweden'. , 1991, European heart journal.